SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-010288
Filing Date
2024-02-29
Accepted
2024-02-29 09:10:25
Documents
14
Period of Report
2024-02-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20022767_8k.htm   iXBRL 8-K 30118
  Complete submission text file 0001140361-24-010288.txt   165207

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ions-20240228.xsd EX-101.SCH 3874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20240228_lab.xml EX-101.LAB 21966
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20240228_pre.xml EX-101.PRE 16050
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20022767_8k_htm.xml XML 4056
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 24699233
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)